Evidence map›Paper›PMID 23700470›Full record

ArticlePloS one2013

Detection of JC virus-specific immune responses in a novel humanized mouse model.

Chen Sabrina Tan, Thomas A Broge, Edward Seung, Vlad Vrbanac, Raphael Viscidi, Jennifer Gordon, Andrew M Tager, Igor J Koralnik

Abstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2017
    Review
  9. Article
  10. Humanized Mouse Models of Clinical Disease.Annual review of pathology · 2017
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Immune reconstitution after allogeneic hematopoietic stem cell transplantation is associated with selective control of JC virus reactivation.Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2014
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chen Sabrina TanDivision of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA. ctan@bidmc.harvard.edu
Thomas A Broge
Edward Seung
Vlad Vrbanac
Raphael Viscidi
Jennifer Gordon
Andrew M Tager
Igor J Koralnik

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
Role of Inflammation in Progressive Multifocal LeukoencephalopathyR01NS047029 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI KORALNIK, IGOR J. · 2004 to 2018
$6.4M
Pathogenesis of a JC Virus Variant in Pyramidal NeuronsR01NS074995 · NINDS · RUSH UNIVERSITY MEDICAL CENTER · PI KORALNIK, IGOR J. · 2012 to 2016
$1.8M
JC Virus Primary Infection, Latency, and ReactivationK08NS064215 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TAN, CHEN SABRINA · 2009 to 2013
$865k
Translational applications of Progressive Multifocal Leukoencephalopathy studiesK24NS060950 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KORALNIK, IGOR J. · 2008 to 2012
$707k
Cellular Immunity to JC Virus in AIDS-Associated Progressive Multifocal LeukoenceR56NS041198 · NINDS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KORALNIK, IGOR J. · 2010 to 2010
$435k
NIAID NIH HHS P30 AI060354NIAID NIH HHS P30 AI60354NIAID NIH HHS T32 AI007061NINDS NIH HHS K08 NS064215NINDS NIH HHS K08 NS 064215-01NINDS NIH HHS K24 NS 060950NINDS NIH HHS K24 NS060950NINDS NIH HHS NS 074995NINDS NIH HHS NS R56 041198NINDS NIH HHS R01 NS 047029NINDS NIH HHS R01 NS047029NINDS NIH HHS R01 NS074995
6 · The paper itself

Abstract

Progressive Multifocal Leukoencephalopathy (PML) is an often fatal disease caused by the reactivation of the JC virus (JCV). Better understanding of viral-host interactions has been hampered by the lack of an animal model. Engrafting NOD/SCID/IL-2-Rg (null) mice with human lymphocytes and thymus, we generated a novel animal model for JCV infection. Mice were inoculated with either a PML isolate, JCV Mad-4, or with JCV CY, found in the kidney and urine of healthy individuals. While mice remained asymptomatic following inoculation, JCV DNA was occasionally detected in both the blood and the urine compartments. Mice generated both humoral and cellular immune responses against JCV. Expressions of immune exhaustion marker, PD-1, on lymphocytes were consistent with response to infection. Using this model we present the first in vivo demonstration of virological and immunological differences between JCV Mad-4 and CY. This model may prove valuable for studying JCV host immune responses.

Indexed as

AnimalsAntibodies, ViralAntigens, DifferentiationAntigens, ViralCapsid ProteinsChlorocebus aethiopsCOS CellsDisease Models, AnimalDNA, ViralHumansImmunity, CellularImmunity, HumoralJC VirusKidneyLeukoencephalopathy, Progressive MultifocalMiceAntibodies, ViralAntigens, DifferentiationAntigens, ViralCapsid ProteinsDNA, ViralPdcd1 protein, mouseProgrammed Cell Death 1 Receptor

Identifiers

PMID23700470
PMCPMC3658964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.